Barclays’s Capricor Therapeutics CAPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.57M Buy
314,792
+195,420
+164% +$5.21M ﹤0.01% 1470
2025
Q4
$3.45M Buy
119,372
+64,279
+117% +$839K ﹤0.01% 2513
2025
Q3
$397K Sell
55,093
-75,818
-58% -$558K ﹤0.01% 3946
2025
Q2
$1.3M Buy
130,911
+53,362
+69% +$564K ﹤0.01% 3158
2025
Q1
$736K Sell
77,549
-12,101
-13% -$168K ﹤0.01% 3287
2024
Q4
$1.24M Buy
89,650
+53,354
+147% +$935K ﹤0.01% 3231
2024
Q3
$552K Buy
36,296
+18,724
+107% +$92.6K ﹤0.01% 3714
2024
Q2
$83.8K Buy
+17,572
New +$98K ﹤0.01% 3991
2021
Q4
Sell
-6,330
Closed -$25K 4168
2021
Q3
$25K Buy
6,330
+4,501
+246% +$20.5K ﹤0.01% 4329
2021
Q2
$9K Buy
1,829
+1,731
+1,766% +$7.33K ﹤0.01% 4670
2021
Q1
$0 Buy
+98
New +$564 ﹤0.01% 4727

Other funds holding CAPR